Investors in Services

Malta VC

VC Firm

The MVC manages a €10 million fund by investing equity in start-up companies operating within the digital economy and innovative economic sectors that contribute significant value to the Maltese economy. Eligible companies may include those involved in video game development, fintech, e-sports, life sciences, pharma, green energy, the filming industry, agritech, AI, communications, electronics, financial services, medical devices, software, bluewater industries, and digital technology. Start-up companies operating in innovative economic sectors will have access to the newly established fund, with each start-up being eligible for up to €500,000 in the form of equity investment. The investment by the fund will be pari-passu with that of private venture capital investors. The Malta Government Venture Capital Limited will be the sole entity responsible for administering this scheme.

Malta β€’Pre-Seed / Seed
€100k-€1.5M

BlackFin Capital Partners is the leading pan-European Financial Services PE Platform. Our four founding partners: Laurent Bouyoux, Eric May, Bruno Rostain and Paul Mizrahi have worked together as senior executives and entrepreneurs in the financial industry for decades. Altogether the team consists of +35 experienced professionals from several nationalities. Our Buyout strategy invests in financial businesses across continental Europe with high-growth potential via organic growth or acquisitions. BlackFin targets asset-light businesses such as: asset management, institutional and retail brokerage, distribution of insurance and banking products, payments, debt management and collection, fund administration, business process outsourcing, financial technology providers and software editors. Our VC strategy focuses on FinTechs, InsurTechs and RegTechs. BlackFin operates as a controlling investor through majority or minority stakes alongside founders, managers or institutional investors, supporting management teams in taking their businesses to the next level. We transform our portfolio companies via organic growth, improving operating margins and through active buy and build strategies. Transactions have been executed in France, Germany, Italy, Spain, Switzerland, Benelux, the Nordics, the Baltics and the UK from our three offices in Paris, Brussels and Frankfurt.

France β€’Pre-Seed / Seed, Series A/B, Series C & Beyond
Above €3M

Vasgos

VC Firm

Vasgos is an investment holding company founded by Pascal and Lorraine ODDO in 2015, later joined by Axel ODDO in 2019. With a global presence, Vasgos operates across five main sectors: Oddo Vins & Domaines, Oddo Bois & Γ‰nergie, listed investments, real estate, and holdings in SME-MidCaps both directly and through private equity funds. Their investment strategy is rooted in core values of entrepreneurship, expertise, and impact. Vasgos partners closely with their stakeholders, sharing long-term ambitions to drive sustainable growth and innovation across their diversified portfolio.

France β€’Series A/B
€1.5M-€3M

GENEO Capital Entrepreneur is dedicated to enabling positive finance for the real economy. Specializing in investing in and supporting the growth of Small and Medium-sized Enterprises (SMEs) and Intermediate-sized Enterprises (SMIs), GENEO focuses on fostering their long-term development projects. With a mission-driven approach, GENEO seeks to contribute to sustainable economic growth by providing capital and strategic support to SMEs and SMIs. This includes partnering with ambitious entrepreneurs to scale their businesses, drive innovation, and create lasting value. Through its commitment to the real economy, GENEO aims to make a meaningful impact by empowering businesses to thrive and succeed in their growth journeys.

France β€’Pre-Seed / Seed, Series A/B
Above €3M

Firlej Kastory is a family investment firm focused on investments in global technology companies, specifically in the energy, financial, risk governance and health sectors. We are an international group based in Warsaw. Our focus is to preserve and increase wealth by achieving long-term returns coupled with a positive social and cultural impact. The firm activity is based on a strong commitment to professional excellence, moral integrity, personal trust, and confidentiality.

Poland β€’Pre-Seed / Seed
€100k-€1.5M

In 1999, the CEA established CEA Valorisation, a wholly-owned subsidiary aimed at promoting patents and investing in startups based on CEA technologies. In 2008, it transformed into CEA Investissement, focusing on direct investments in companies leveraging CEA innovations. Specifically, CEA Investissement invests during the startup creation phase, providing initial funding based on innovations stemming from CEA research. It also offers comprehensive support for the scientific and commercial development of these young companies, whether they are spin-offs or linked to CEA through research contracts.

France β€’Pre-Seed / Seed, Series A/B, Series C & Beyond
Above €3M

LOREA AG

VC Firm

LOREA AG is a diversified industrial holding company which invests equity capital from entrepreneurs and from family businesses that have been successfully managed for generations.

Switzerland β€’Series A/B
Above €3M

360 Capital

VC Firm

Our firm has been on the forefront of financing innovation for over 25 years. Since our inception in the late 90’s, we’ve consistently managed to anticipate technology trends and spot talented entrepreneurs pursuing ambitiously disruptive goals. We were among the first to see the power of eCommerce and successfully rode the first wave of digital transition in the 2000’s, investing in emerging B2C/B2B plays in a variety of sectors. With the steady growth of our firm and the maturing of the European Venture Capital ecosystem, we gradually transitioned our investment focus to more tech-heavy initiatives. Over the past 10 years, deep-tech and climate-tech have grown to become a substantial aspect of our investment activities.

France β€’Pre-Seed / Seed, Series A/B, Series C & Beyond
Above €3M

Alven

VC Firm

Alven is an independent early-stage venture capital firm managing over $500m, known for backing 130+ startups across 20 years. They focus on supporting European startups with global potential, specializing in sectors like B2C/B2B marketplaces, productivity tools, AI platforms, social & entertainment, financial services, and wellness brands. Some notable investments include Akeneo, Dataiku, Algolia, Happn, MeilleursAgents, and Birchbox. Alven actively seeks innovative startups at the Series A or Seed stage to partner with for long-term success and growth.

France β€’Pre-Seed / Seed, Series A/B
Above €3M

A global leader in developing and producing responsible packaging for food, beverage, pharma, medical, home- and personal-care, and other products. Amcor works with leading companies around the world to protect their products and the people who rely on them, differentiate brands, and improve supply chains through a range of flexible and rigid packaging, specialty cartons, closures, and services. The company is focused on making packaging that is increasingly light-weighted, recyclable and reusable, and made using an increasing amount of recycled content.

Switzerland β€’Pre-Seed / Seed, Series A/B, Series C & Beyond
0-€100k

Reference Capital is a privately held advisory firm dedicated to researching and investing in disruptive technologies which will transform the world we live in. Our team is composed of seasoned VC investors and family office managers primarily based in Geneva, Switzerland with presence in London, New York, Seattle, Tel Aviv, and Dubai. Reference Capital has built the ecosystem needed to find, track and access best-in-class Venture Funds that will drive outperformance for our clients. We provide investment advisory services to institutional investors, including some of the most influential industrial families, foundations, pensions, private clients, corporate and government entities.

Switzerland β€’Series A/B, Series C & Beyond
€1.5M-€3M

Omega Funds

VC Firm

Omega Funds is a leading international investment firm that creates and invests in life sciences companies that target the world's most urgent medical needs. Ω is the last letter of the Greek alphabet. Our investment process starts by focusing on the end goal – delivering impactful medicines to patients. We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas, including oncology, immunology, rare diseases, precision medicine and others. Early seed or late stage public financing. Large markets or rare diseases. Established targets or novel technologies.

Switzerland β€’Series A/B, Series C & Beyond
Above €3M
Showing 1-12 of 954 items